<!doctype html>
<html lang="en">
<head>

    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <title>PRIM4BC</title>


    <!-- Bootstrap core CSS -->
    <link href="https://diagnijmegen.github.io/website-pathology/theme/css/theme.min.css" rel="stylesheet">
</head>

<body>

<nav class="navbar navbar-expand-md navbar-light bg-white fixed-top">
    <div class="container">
        <a class="navbar-brand" href="https://diagnijmegen.github.io/website-pathology/">
            <span class="name-full">Computational Pathology Group</span>
            <span class="name-short">CPG</span>
        </a>
        <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarsExampleDefault" aria-controls="navbarsExampleDefault" aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
        </button>

        <div class="collapse navbar-collapse" id="navbarsExampleDefault">
            <ul class="navbar-nav ml-auto">
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/about">About</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/news">News</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/people">People</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/projects">Projects</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/vacancies">Vacancies</a>
                </li>
                <li class="nav-item">
                    <a class="nav-link" href="https://diagnijmegen.github.io/website-pathology/Contact">Contact</a>
                </li>
            </ul>
        </div>
    </div>
</nav>
    <main role="main">
    <div class="container">
    <h1>PRIM4BC</h1>
    

    <p>PRIM4BC</p>
<p>Background</p>
<p>Approximately 20% of
all breast cancers are so-called triple-negative (TNBC), indicating their lack
of overexpression of oestrogen and progesterone receptor and human epidermal
growth factor receptor 2. These cancers are associated with an increased risk
of recurrence, even for very small (&lt;1cm) tumours. There is a tendency to
administer adjuvant chemotherapy even to limited stage TNBC patients. This
results, however, in substantial overtreatment, accompanied by unnecessary
mortality, morbidity and costs. On the other site, approximately 25% of TNBC
patients will be faced with a locoregional or distant recurrence, usually within
4 years after initial diagnosis. Advanced TNBC has an extremely poor prognosis
with a median survival of only 13 months. Up to date, it is a priori unclear
which patients will get a recurrence. Prognostic biomarkers are therefore
urgently needed, enabling clinicians to select TNBC patients for adjuvant
chemotherapy who are at increased risk of recurrence.</p>
<p>Promising results were
published on the prognostic value of tumour infiltrating lymphocytes (TIL) in
TNBC, using immunohistochemically (IHC) stained tissue sections. Also, mitotic
count was found to yield prognostic information. To date, assessment of these
biomarkers lack standardisation, resulting in large variations in published
results and hampering clinical implementation.</p>
<p>Aim of the project</p>
<p>In this project we
will apply advanced digital image analysis to obtain prognostic data from
H&amp;E and IHC stained sections. Statistical techniques will subsequently be
used to derive a model offering the strongest possible prognostic data. The
model will be able to predict TNBC recurrence and survival within 5 years.</p>
<p>Publications or media attention</p>
<p>Tellez D, Balkenhol M,
Otte-Holler I, van de Loo R, Vogels R, Bult P, Wauters C, Vreuls W, Mol S,
Karssemeijer N, Litjens G, van der Laak J, Ciompi, F. Whole-Slide Mitosis
Detection in H&amp;E Breast Histology Using PHH3 as a Reference to Train
Distilled Stain-Invariant Convolutional Networks. Accepted in IEEE Trans Med
Imaging. 2018.</p>
<p>First prize OOR ON
Onderzoeksprijs (clinical residents' science award), Nijmegen, The Netherlands,
2017.</p>
<p>Balkenhol MCA,
Ehteshami Bejnordi B, Otte-HÃ¶ller I, de Boer O, Nap M, van Dijk M, Damen J,
Nooijen P, Baidoshvili A, Karssemeijer N, van der Laak J. Improved assessment
of IHC staining quality applying quantitative measures. Poster presentation,
Digital Pathology Conference, December 2015, London, Great Britain.</p>

    </div>
    </main>

<footer class="footer">
    <div class="container">
        <div class="row">
            <div class="col-md-8 py-3 footer-content">
                <p>&copy; Computational Pathology Group 2017-2018</p>
                <p>The Computational Pathology Group is part of the <a href="http://www.diagnijmegen.nl">Diagnostic Image Analysis Group</a> and the Department of Pathology at <a href="https://www.radboudumc.nl">Radboud University Medical Center</a>.</p>

                <a href="https://github.com/diagnijmegen/website-pathology/edit/master/content/pages/projects/prim4bc.md">Edit</a>
            </div>

            <div class="col-md-4 footer-ribbon py-3">
                <h3>Contact</h5>
                <address>
                    <strong>Computational Pathology Group</strong><br>
                    <i>Radboud University Medical Center</i><br>
                    Geert Grooteplein 10<br>
                    6525 GA Nijmegen<br>
                    The Netherlands<br>
                </address>
            </div>
        </div>
    </div>
</footer>
    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js" integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl" crossorigin="anonymous"></script>
</body>
</html>